Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does HLA explain the high incidence of childhood-onset type 1 diabetes in the Canary Islands? The role of Asp57 DQB1 molecules.
Nóvoa-Medina Y, Marcelino-Rodriguez I, Suárez NM, Barreiro-Bautista M, Rivas-García E, Sánchez-Alonso S, González-Martínez G, Quinteiro-González S, Domínguez Á, Cabrera M, López S, Pavlovic S, Flores C; Gran Canarian Diabetes and Obesity Research Group; Wägner AM. Nóvoa-Medina Y, et al. Among authors: wagner am. BMC Pediatr. 2024 Sep 6;24(1):569. doi: 10.1186/s12887-024-04983-w. BMC Pediatr. 2024. PMID: 39243072 Free PMC article.
Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, Nóvoa FJ. Boronat M, et al. Among authors: wagner am. Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):417-22. doi: 10.1016/j.numecd.2008.07.010. Epub 2008 Sep 25. Nutr Metab Cardiovasc Dis. 2009. PMID: 18819785
Is HLA the cause of the high incidence of type 1 diabetes in the Canary Islands? Results from the Type 1 Diabetes Genetics Consortium (T1DGC).
Santana Del Pino A, Medina-Rodríguez N, Hernández-García M, Nóvoa-Mogollón FJ, Wägner AM; Spanish Type 1 Diabetes Genetics Network, T1DGC. Santana Del Pino A, et al. Among authors: wagner am. Endocrinol Diabetes Nutr. 2017 Mar;64(3):146-151. doi: 10.1016/j.endinu.2016.12.003. Epub 2017 Feb 16. Endocrinol Diabetes Nutr. 2017. PMID: 28440753 English, Spanish.
Autosomal recessive hypercholesterolemia in Spain.
Sánchez-Hernández RM, Prieto-Matos P, Civeira F, Lafuente EE, Vargas MF, Real JT, Goicoechea FG, Fuentes FJ, Pocovi M, Boronat M, Wägner AM, Masana L. Sánchez-Hernández RM, et al. Among authors: wagner am. Atherosclerosis. 2018 Feb;269:1-5. doi: 10.1016/j.atherosclerosis.2017.12.006. Epub 2017 Dec 6. Atherosclerosis. 2018. PMID: 29245109
Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial.
Wägner AM, Miranda-Calderín G, Ugarte-Lopetegui MA, Marrero-Santiago H, Suárez-Castellano L, Alberiche-Ruano MDP, Castillo-García N, López-Madrazo MJ, Alemán C, Martínez-Mancebo C, López-Ríos L, Díez Del Pino A, Nóvoa-Mogollón FJ. Wägner AM, et al. Contemp Clin Trials Commun. 2016 Jun 24;4:46-51. doi: 10.1016/j.conctc.2016.06.007. eCollection 2016 Dec 15. Contemp Clin Trials Commun. 2016. PMID: 29736469 Free PMC article.
Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2).
Wägner AM, Miranda-Calderín G, Ugarte-Lopetegui MA, Marrero-Santiago H, Suárez-Castellano L, López-Madrazo MJ, Alberiche-Ruano MP, Abselam Ahmed N, Alemán C, Castellot-Martín A, Díez Del Pino A, Nóvoa-Mogollón FJ. Wägner AM, et al. Diabetes Metab. 2019 Jun;45(3):268-275. doi: 10.1016/j.diabet.2018.08.010. Epub 2018 Sep 14. Diabetes Metab. 2019. PMID: 30223083 Clinical Trial.
238 results